Company information
- Ticker
- CTEV
- Country
- United States
- Sector
- Health Care
- Industry
- Health Care Technology
Claritev Business Summary
Claritev Corp (CTEV), formerly known as MultiPlan Corporation, operates as a leading provider of data analytics and technology-enabled cost management, payment, and revenue integrity solutions for the U.S. healthcare industry. The company generates revenue primarily through a combination of transaction-based fees, which are calculated as a percentage of the savings realized by its clients, and subscription-based access to its proprietary healthcare networks and analytics platforms. Its business is structured into three primary segments: Payment Integrity, which utilizes clinical rules and AI to identify improper claims; Network-Based Services, providing access to independent provider networks; and Analytics-Based Services, which offer data-driven pricing and reimbursement benchmarks. Claritev competes directly with TruBridge, Definitive Healthcare, HealthStream, and Zelis Healthcare, positioning itself as a high-capacity aggregator that bridges the gap between payors and providers to drive transparency and affordability across the healthcare ecosystem. The company is currently led by Chairman and CEO Travis Dalton, who joined in March 2024 following a distinguished tenure as General Manager and Executive Vice President of Oracle Health. The executive team is heavily composed of former Oracle Health and Cerner veterans, including CFO Doug Garis, COO Jerry Hogge, and Chief Medical Officer Dr. Jigar Patel, reflecting a strategic shift toward a tech-centric, AI-driven business model. Michael Kim serves as the Chief Digital Officer, overseeing the company’s technological transformation alongside Chief AI Officer Fernando Schwartz, formerly of ADP and Merck. Claritev’s board of directors features notable industry figures such as John M. Prince, an Operating Partner at Advent International and former President of Optum, and Allen R. Thorpe of Hellman & Friedman. The company maintains strong institutional backing from major private equity firms including Hellman & Friedman and TPG Global, which have been instrumental in its evolution from a legacy network provider to a modern healthcare data powerhouse.